First U.S. Patients Enrolled in Virtus Trial for Venous Stenting

December 22, 2014 — Veniti Inc. announced that it has enrolled the first United States patients in the Virtus trial of the Veniti VICI Venous Stent System. The four procedures were performed at two sites, including the Heart and Vascular Center, St. Joseph Hospital, Orange, Calif.

The VICI Venous Stent System was designed to be compatible with the unique anatomy and pathophysiology of the venous system, including crush resistance, vessel coverage and flexibility. It is intended for use in veins of the lower extremities and pelvis, including the iliac and common femoral veins, in patients who exhibit symptomatic venous outflow obstruction. This condition is frequently associated with disorders of the lower extremities, such as varicose veins and venous ulcers.

For more information: www.veniti.com